|
WO2021019421A2
|
|
Ascorbate in the prevention of statin induced vascular calcification
|
|
US2021030715A1
|
|
Ascorbate in the prevention of statin induced vascular calcification
|
|
EP3508211A1
|
|
Composition for eye health
|
|
HUE045060T2
|
|
Method for producing a foamed ceramic
|
|
EP2915485A1
|
|
Computer-implemented method and system for testing or training a user's cognitive functions
|
|
EP2846243A1
|
|
Graphical user interface providing virtual super-zoom functionality
|
|
EP2862108A1
|
|
Integrated interactive system and method for visualizing human physiology, disease, treatment options and use
|
|
US2008248130A1
|
|
Composition and Method For the Promotion of Hair Growth on a mammal
|
|
US2008008721A1
|
|
Preventive and therapeutic use of polypeptides from African Swine virus as vaccines
|
|
US2008131449A1
|
|
Polypeptides from African Swine Fever virus as vaccines for preventive and therapeutic use
|
|
US2007265211A1
|
|
Novel composition and method effective in inhibiting the atherogenic process
|
|
US2007212426A1
|
|
Composition and method of retarding viral activity and reducing viral replication
|
|
KR20080016547A
|
|
Nutrient composition comprising green tea polyphenols for treating osteosarcoma
|
|
KR20080016548A
|
|
Nutrient compositon for treating sarcoma and prostate cancer
|
|
BRPI0520227A2
|
|
Use of a Nutrient Composition for the Treatment of Sarcoma and Prostate Cancer
|
|
BRPI0520221A2
|
|
Use of a nutrient composition comprising green tea polyphenols for treating osteosarcoma
|
|
US7300918B2
|
|
Method of producing vaccines from protein signal oligopeptides
|
|
LT2004079A
|
|
Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis
|
|
LV13225B
|
|
Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
|
|
LT2004065A
|
|
Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances
|
